Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  cholecalciferol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 40 for your search:
Start Over
VITamine D Supplementation in RenAL Transplant Recipients - VITALE
Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: P100103, NCT01431430
Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients
Phase: Phase IV
Type: Supportive care
Status: Enrolling by invitation
Age: 20 to 79
Sponsor: Other
Protocol IDs: CKDR-001, UMIN000009970, NCT01817699
Vitamin D/Calcium Polyp Prevention Study
Phase: Phase III, Phase II
Type: Prevention
Status: Closed
Age: 45 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 CA098286-03, 5R01CA098286-10, NCT00153816
Phase III Randomized Study of Zoledronate in Patients With Bone Metastases Secondary to Prostate Cancer (Summary Last Modified 12/1999)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-4244603039
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068781, U10CA031946, CALGB-79809, NCI-P01-0184, NCT00022087
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069502, NCCTG-N01C8, NCI-P02-0229, N01C8, NCT00043069
Phase III Hormone Therapy with FXM Plus Calcium Carbonate/Vitamin D and Calcitonin for Recurrent Breast Carcinoma with Osseous Metastases
Phase: Phase III
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: CBCG-4400
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N02C1, NCI-2012-02515, CDR0000270449, N02C1, NCT00054418
A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: BONEII, NCT00186901
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0518, CDR0000476469, NCI-2009-00884, 0518, NCT00329797
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27
Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: MA27B, CAN-NCIC-MA27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, CDR0000483099, NCIC-MA.27B, NCT00354302
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 02U1, NCT00058188
Vitamin D and Omega-3 Trial (VITAL)
Phase: Phase III
Type: Prevention
Status: Closed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 2009P-001217, NCT01169259
Phase I/II Study of Therapy with Vit D3 in Patients with Advanced Indolent Lymphomas and Chronic Lymphocytic Leukemia (Summary Last Modified 04/88)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: IOWA-V87-0191, NCI-V87-0191
Phase II Chemoprevention Study of Vitamin D3 and Calcium for Colorectal Cancer (Summary Last Modified 01/98)
Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CPMC-IRB-6850, NCI-P97-0109
Calcifidol Therapy in Men With Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ONCO-09-99S, NCT00018538
Calcium and Vitamin D vs Markers of Adenomatous Polyps
Phase: Phase II
Type: Prevention
Status: Completed
Age: 30 to 74
Sponsor: NCI, Other
Protocol IDs: 0126-2004, R01CA104637, NCT00208793
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005NT018, UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, UMN-2005NT018, NCT00321932
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000554969, P30CA012197, CCCWFU-85106, CCCWFU-IRB00000371, NCT00499408
Vitamin D in Treating Patients With Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000562742, I 95406, RPCI-I-95406, NCT00524680
Vitamin D Effects on Prostate Pathology
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 30 to 85
Sponsor: Other
Protocol IDs: M2140, NCT00741364
Start Over